BAKX Ther­a­peu­tics to shut down af­ter ‘sci­en­tif­ic chal­lenges’ and fi­nanc­ing dol­drums

BAKX Ther­a­peu­tics will shut down by Aug. 1, end­ing a “Thel­ma and Louise” ap­proach to can­cer small mol­e­cules af­ter sci­en­tif­ic, fi­nanc­ing and time­line chal­lenges up­end­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER